Portfolio Lab

Ufp Technologies Inc

  • Stock
  • Ticker UFPT
  • ISIN US9026731029
  • Nasdaq

Health care · Medical technology · USA

$290.85 −2.70%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Ufp Technologies Inc since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

UFPTGlobal equities (VT)

$10,000 grew to $111,224. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −48.3% in 10/2025, measured from the peak in 09/2024. The old peak has not been reached again yet.

1-year return
+38.6%
5-year return p.a.
+33.2%
10-year return p.a.
+27.2%
Volatility p.a.
35.1%
Largest decline
−48.3%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue144148151155149154174172
Gross profit4242444342445151
Operating income2223242322232828
EBITDA2728292134263130
Net income1617171618172121
Earnings per share2.102.212.212.112.252.242.682.64
Balance sheet
Total assets629643635653655675682683
Liabilities286282249249231236219197
Equity343361385404424439462486
Cash1314151820209.021
Long-term debt17717015113412312510584
Cash flow
Operating cash flow24142536173.21639
Capital expenditure-3.0-2.8-2.9–––––
Free cash flow21112236173.21639

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2022 at +67.8%, weakest 2025 at −9.2%. 7 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
6 Nov 2026$2.64
6 Aug 2026$2.68
8 May 2026$2.24
27 Feb 2026$2.25
7 Nov 2025$2.11
11 Aug 2025$2.21
12 May 2025$2.21
3 Mar 2025$2.10
12 Nov 2024$2.11
9 Aug 2024$1.75
10 May 2024$1.64
29 Feb 2024$1.51

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€2.0bn
Market cap in trading currency
$2.25bn
Enterprise value
$2.33bn
P/E
29.6
P/S
3.47
P/B
4.64
EV/Sales
3.59
EV/EBITDA
19.4
Earnings yield
3.4%
FCF yield
3.3%

Results (last four quarters)

Revenue
$650m
Gross profit
$188m
EBITDA
$120m
Net income
$76.5m
Earnings per share
$9.81
Revenue per share
$83.84
Revenue growth
+11.6%
Earnings growth
+25.8%

Profitability

Gross margin
28.9%
Operating margin
15.5%
Net margin
11.8%
Return on equity
17.2%
Return on assets
11.2%

Balance sheet and cash flow

Cash
$20.6m
Cash per share
$2.66
Financial debt
$96.0m
Debt/equity %
20
Current ratio
2.98
Book value per share
$62.70
Operating cash flow
$74.2m
Free cash flow
$74.2m

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
0%
Ex-dividend date
–

Shares and trading

Shares outstanding
7.75m
Volume
117,164
Avg. volume 3 months
112,976
Relative volume
1.1

Price and technicals

Price
$290.85
1 day
−2.7%
52-week high
$334.84
52-week low
$185.45
Distance to 52-week high
−13.1%
Distance to 52-week low
+56.8%
Distance to 50-day line
−1.3%
Distance to 200-day line
+15.0%
RSI (14)
46
Volatility 1M
74.9%

Performance

1 week
−4.7%
1 month
−2.2%
3 months
−4.8%
6 months
+27.0%
YTD
+31.0%
1 year
+32.5%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has UFPT performed since 11/2016?

$10,000 grew to $111,224 by 20 Nov 2026, which is +27.3% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is UFPT?

Volatility was 35.1% per year, measured on monthly returns. The largest decline from a peak was −48.3%, with the low in 10/2025.

How does UFPT compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, UFPT returned +27.3% at 35.1%. The correlation of monthly returns was 0.46; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Ufp Technologies Inc (UFPT): Return and risk | Portfolio Lab